„Nutlin“
Suchergebnisse
1.000+ Treffer
-
Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53
-
Fibroid explants reveal a higher sensitivity against MDM2-inhibitor nutlin-3 than matching myometrium
-
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
-
A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation
-
MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines
-
Protection of p53 wild type cells from taxol by nutlin-3 in the combined lung cancer treatment
-
Induction of synergistic apoptosis by tetramethoxystilbene and nutlin-3a in human cervical cancer cells
-
The evolution of Nutlins as p53-MDM2 inhibitors
-
Targeting MDM2, the antagonist of the tumor suppressor p53
-
p53-Inaktivierung im Melanom - ein therapeutischer Ansatzpunkt?
-
Correction to: Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways
-
Nutlin-3a-aa – Improving the Bioactivity of a p53/MDM2 Interaction Inhibitor by Introducing a Solvent-Exposed Methylene Group
-
Nutlin 3a aa Improving the Bioactivity of a p53 MDM2 Interaction Inhibitor by Introducing a Solvent Exposed Methylene Group
-
Acetalated Dextran Nanoparticles Loaded into an Injectable Alginate Cryogel for Combined Chemotherapy and Cancer Vaccination
-
Cancer Therapy: Nutlin‐3a and Cytokine Co‐loaded Spermine‐Modified Acetalated Dextran Nanoparticles for Cancer Chemo‐Immunotherapy (Adv. Funct. Mater. 42/2017)
-
Effective and Practical Stereoselective Synthesis of Nutlins Precursors by Immobilization of Privileged Chiral Mono‐Amidine Catalyst
-
Sustained correction of hippocampal neurogenic and cognitive deficits after a brief treatment by Nutlin-3 in a mouse model of fragile X syndrome
-
Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents
-
Nutlin‐3a and Cytokine Co‐loaded Spermine‐Modified Acetalated Dextran Nanoparticles for Cancer Chemo‐Immunotherapy
-
Strong activation of p53 by actinomycin D and nutlin-3a overcomes the resistance of cancer cells to the pro-apoptotic activity of the FAS ligand